Jeanette Leusen | Associate Professor, Laboratory, Translational Immunology
UMC Utrecht

Jeanette Leusen, Associate Professor, Laboratory, Translational Immunology, UMC Utrecht

Dr. Jeanette Leusen, received her PhD in 1995 at the University of Amsterdam (UvA), The Netherlands, studying neutrophils. Now she is PI on antibody therapy in the University Medical Center of an academic group of 22 FTE. She has co-authored 120 publications and is co-inventor on 10 patent applications. She is also scientific founder of a company called TigaTx developing engineered IgA for therapeutic application in oncology.

Appearances:



Festival of Biologics Day 2 @ 17:40

IgA tot target MDSC in the TME

  • IgA is very potent in activating neutrophils to kill cancer cells
  • Can suppressive myeloid cells (MDSC) still killtumorcells?
  • Can IgA revert or prevent the suppressive phenotype of M+DSC?
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT
last published: 17/Sep/21 16:05 GMT

back to speakers